Literature DB >> 7969261

Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy.

E F Wijdicks, J R Fulgham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7969261

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  10 in total

1.  Critical Illness Polyneuropathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

2.  Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator.

Authors:  F S Leijten; A W De Weerd; D C Poortvliet; V A De Ridder; C Ulrich; J E Harink-De Weerd
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 3.  Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.

Authors:  Efstratios Apostolakis; Nikolaos A Papakonstantinou; Nikolaos G Baikoussis; George Papadopoulos
Journal:  J Anesth       Date:  2014-07-01       Impact factor: 2.078

Review 4.  [Intensive care unit acquired weakness. Pathogenesis, treatment, rehabilitation and outcome].

Authors:  M Ponfick; K Bösl; J Lüdemann-Podubecka; G Neumann; M Pohl; D A Nowak; H-J Gdynia
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

5.  Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis.

Authors:  M Mohr; L Englisch; A Roth; H Burchardi; S Zielmann
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

6.  Diagnosis and management of critical illness polyneuropathy and critical illness myopathy.

Authors:  Shawn J Bird
Journal:  Curr Treat Options Neurol       Date:  2007-03       Impact factor: 3.598

Review 7.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 8.  Approach to neuromuscular disorders in the intensive care unit.

Authors:  Kenneth C Gorson
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

9.  The Prevalence and Outcome of Intensive Care Unit Acquired Weakness (ICUAW).

Authors:  Ali Panahi; Majid Malekmohammad; Fereshteh Soleymani; Seyed Mohammadreza Hashemian
Journal:  Tanaffos       Date:  2020-07

10.  Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial.

Authors:  Richard Brunner; Walter Rinner; Christine Haberler; Reinhard Kitzberger; Thomas Sycha; Harald Herkner; Joanna Warszawska; Christian Madl; Ulrike Holzinger
Journal:  Crit Care       Date:  2013-10-02       Impact factor: 9.097
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.